Infection Control Today® Editorial Staff


Update: Eli Lilly’s Anti-COVID Product Approved by FDA

November 11, 2020

Bamlanivimab, a monoclonal antibody, can be used for anyone 65 or older. It can also be used for patients 12 and over who have an underlying health condition and have been diagnosed with mild-to-moderate COVID-19.